Using a new total-body PET scanner to improve cancer imaging
Basic applications for total-body PET in oncology
['FUNDING_R01'] · UNIVERSITY OF CALIFORNIA AT DAVIS · NIH-10694879
This study is testing a new total-body PET scanner that aims to make cancer imaging faster and clearer for patients with lung cancer, lymphoma, and melanoma who need scans before starting treatment.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF CALIFORNIA AT DAVIS (nih funded) |
| Locations | 1 site (DAVIS, UNITED STATES) |
| Trial ID | NIH-10694879 on ClinicalTrials.gov |
What this research studies
This research investigates a groundbreaking total-body PET scanner designed to enhance cancer imaging by significantly reducing scan times and improving image quality. The study will enroll 360 patients with lung cancer, lymphoma, and melanoma who are referred for PET/CT scans before starting treatment. Researchers will explore various aspects of the scanner's performance, including the feasibility of breath-hold imaging and the potential for reduced doses of radiotracer. The goal is to determine if this innovative technology can provide diagnostic images comparable to traditional methods in a much shorter time frame.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with lung cancer, lymphoma, or melanoma who require PET/CT scans for initial staging.
Not a fit: Patients with other types of cancer or those who do not require PET/CT imaging may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to faster and safer cancer imaging, improving the overall patient experience and potentially enhancing treatment outcomes.
How similar studies have performed: Other research has shown promise with advanced imaging technologies, but this specific total-body PET scanner represents a novel approach in oncology.
Where this research is happening
DAVIS, UNITED STATES
- UNIVERSITY OF CALIFORNIA AT DAVIS — DAVIS, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: NARDO, LORENZO — UNIVERSITY OF CALIFORNIA AT DAVIS
- Study coordinator: NARDO, LORENZO
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.